Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 20 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.84 Insider Own80.75% Shs Outstand266.82M Perf Week-5.06%
Market Cap3.78B Forward P/E42.12 EPS next Y0.32 Insider Trans0.00% Shs Float53.80M Perf Month0.07%
Income-494.28M PEG- EPS next Q-0.02 Inst Own6.99% Short Float0.17% Perf Quarter-11.29%
Sales88.00M P/S42.92 EPS this Y84.42% Inst Trans7.71% Short Ratio0.51 Perf Half Y26.03%
Book/sh-2.47 P/B- EPS next Y184.72% ROA-50.54% Short Interest0.09M Perf Year71.66%
Cash/sh0.23 P/C58.28 EPS next 5Y- ROE- 52W Range6.70 - 18.00 Perf YTD17.68%
Dividend Est.- P/FCF- EPS past 5Y- ROI-125.98% 52W High-24.94% Beta-0.06
Dividend TTM- Quick Ratio0.81 Sales past 5Y3.37% Gross Margin-61.04% 52W Low101.64% ATR (14)0.36
Dividend Ex-Date- Current Ratio1.18 EPS Y/Y TTM-27598.51% Oper. Margin-378.86% RSI (14)41.60 Volatility2.58% 2.84%
Employees1026 Debt/Eq- Sales Y/Y TTM- Profit Margin-561.68% Recom2.00 Target Price19.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q22.08% Payout- Rel Volume0.00 Prev Close13.51
Sales Surprise- EPS Surprise-972.29% Sales Q/Q-21.65% EarningsMay 21 AMC Avg Volume182.89K Price13.51
SMA20-3.25% SMA50-1.06% SMA20011.32% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Upgrade Barclays Equal Weight → Overweight $10 → $17
Oct-20-23Upgrade Citigroup Sell → Neutral $5 → $10
Sep-21-23Initiated Barclays Equal Weight $10
Sep-07-22Initiated Morgan Stanley Equal-Weight $10
Sep-06-22Downgrade Citigroup Buy → Sell $12 → $5
Jul-26-22Initiated Citigroup Buy $12
Jun-18-24 04:01AM
Jun-11-24 04:00AM
Jun-07-24 04:00AM
May-29-24 08:05AM
May-21-24 09:52PM
05:15PM Loading…
May-20-24 08:25PM
May-15-24 09:30AM
May-13-24 08:00AM
May-02-24 07:15AM
Apr-30-24 04:00AM
Apr-24-24 04:00AM
Apr-19-24 06:10AM
05:43PM Loading…
Apr-16-24 05:43PM
Apr-03-24 07:41AM
Mar-22-24 04:15PM
Mar-20-24 09:52PM
Mar-05-24 04:01PM
Feb-29-24 04:05PM
Feb-26-24 09:58AM
Feb-23-24 08:15PM
Feb-15-24 06:30AM
Jan-29-24 04:00AM
Jan-22-24 10:03AM
Jan-19-24 11:30AM
Jan-10-24 03:30AM
03:30AM Loading…
Jan-03-24 03:30AM
Dec-29-23 04:05AM
Nov-29-23 04:00AM
Nov-28-23 04:15PM
Nov-21-23 08:00AM
Nov-14-23 07:00AM
Nov-10-23 09:30AM
Nov-07-23 08:00AM
Oct-12-23 04:00AM
Oct-05-23 01:21PM
Oct-03-23 08:29AM
Sep-25-23 04:00AM
Sep-20-23 04:30AM
Sep-11-23 05:00AM
Sep-05-23 09:30AM
Aug-30-23 04:15PM
Aug-29-23 05:00AM
Aug-22-23 09:15AM
Jul-31-23 04:00AM
Jul-26-23 01:30PM
Jul-24-23 04:00AM
Jul-06-23 07:26AM
Jun-28-23 07:00PM
Jun-12-23 07:00AM
May-31-23 05:20AM
May-24-23 05:00AM
May-19-23 05:00AM
May-17-23 05:00AM
May-15-23 05:00AM
May-10-23 05:00AM
May-05-23 09:00AM
May-04-23 05:00AM
May-03-23 09:00AM
Apr-19-23 05:30PM
Apr-13-23 08:45PM
Mar-28-23 05:00AM
Mar-17-23 09:10AM
Mar-01-23 04:30PM
Feb-27-23 07:15PM
Feb-14-23 04:01PM
Feb-10-23 04:01PM
Feb-09-23 02:30AM
Feb-06-23 04:00AM
Jan-24-23 04:00AM
Jan-23-23 03:25AM
Jan-13-23 04:00AM
Jan-11-23 04:00AM
Jan-06-23 07:00AM
Dec-22-22 04:00AM
Dec-16-22 06:45AM
Dec-08-22 03:30AM
Dec-07-22 04:00AM
Dec-02-22 10:41AM
Dec-01-22 05:00PM
Nov-30-22 02:47PM
Nov-16-22 07:27AM
Nov-14-22 02:00AM
Nov-10-22 04:00AM
Oct-27-22 05:00PM
Oct-26-22 05:00PM
Oct-19-22 08:38PM
Oct-17-22 05:00AM
Oct-11-22 05:00PM
Sep-22-22 08:00AM
Sep-05-22 05:00AM
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Robert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.